Medtronic to split diabetes business into separate entity, targets IPO [Yahoo! Finance]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: Yahoo! Finance
The separation will serve to create an “independent, scaled leader in diabetes” that boasts an ecosystem of insulin management devices including pumps and continuous glucose monitors, Medtronic said. The split will also in turn create a wholly “more focused” Medtronic, with a more simplified portfolio in high margin growth markets. Medtronic's shares on the New York Stock Exchange (NYSE) fell by 2.27% at market close following the announcement on 21 May. “It's going to give Medtronic some significant capital to increase their presence in other, more interventional, areas, especially in cardiovascular. They have a history of inorganic expansion, so I can see this as providing ammunition for a big acquisition in 2026-7,” said Dr Andrew Thompson, director of therapy research and analysis in medical devices for GlobalData reacting to the separation. With a preferred path of an initial public offering (IPO) and subsequent split-off, Medtronic anticipates the split to complete with
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [Yahoo! Finance]Yahoo! Finance
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their health [TheStreet.com]TheStreet.com
- New survey finds most Americans believe chronic diseases are preventable, but only 1 in 4 feel confident in how to care for their healthPR Newswire
- Abbott Laboratories (ABT) had its price target raised by Barclays PLC from $142.00 to $144.00. They now have an "overweight" rating on the stock.MarketBeat
- Abbott Laboratories (ABT) had its price target lowered by The Goldman Sachs Group, Inc. from $140.00 to $121.00. They now have a "buy" rating on the stock.MarketBeat
ABT
Earnings
- 1/22/26 - In-Line
ABT
Sec Filings
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- ABT's page on the SEC website